Do <i>Akkermansia</i> mutants underlie the global metabolic disease epidemic?

Antibiotic-induced mutations in <i>Akkermansia muciniphila</i> promote bacterial survival while compromising beneficial host interactions, revealing a potential new link between antibiotic-driven microbiome disruption and metabolic disease. The widespread presence of these mutants suggests that they may contribute to the increasing prevalence of metabolic disorders. If validated in diverse global human cohort studies, these mutants could serve as biomarkers of disease susceptibility and as targets for therapeutic intervention.